Identification of LRRc17 as a Negative Regulator of Receptor Activator of NF-κB Ligand (RANKL)-induced Osteoclast Differentiation
Open Access
- 1 May 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (22), 15308-15316
- https://doi.org/10.1074/jbc.m807722200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and DiseaseEndocrine Reviews, 2007
- OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone MetabolismAnnual Review of Immunology, 2006
- Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated OsteoclastogenesisJournal of Biological Chemistry, 2005
- The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 CellsJournal of Biological Chemistry, 2004
- Genetic regulation of osteoclast development and functionNature Reviews Genetics, 2003
- Osteoclast differentiation and activationNature, 2003
- The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics AssessmentGenome Research, 2003
- Bone Resorption by OsteoclastsScience, 2000
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998